335 related articles for article (PubMed ID: 32514568)
1. Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging.
Szymanska KJ; Tan X; Oktay K
Mol Hum Reprod; 2020 Aug; 26(8):553-566. PubMed ID: 32514568
[TBL] [Abstract][Full Text] [Related]
2. Individual-oocyte transcriptomic analysis shows that genotoxic chemotherapy depletes human primordial follicle reserve in vivo by triggering proapoptotic pathways without growth activation.
Titus S; Szymanska KJ; Musul B; Turan V; Taylan E; Garcia-Milian R; Mehta S; Oktay K
Sci Rep; 2021 Jan; 11(1):407. PubMed ID: 33431979
[TBL] [Abstract][Full Text] [Related]
3. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
Winship AL; Griffiths M; Lliberos Requesens C; Sarma U; Phillips KA; Hutt KJ
Hum Reprod; 2020 Aug; 35(8):1864-1874. PubMed ID: 32604417
[TBL] [Abstract][Full Text] [Related]
4. Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility.
Nguyen QN; Zerafa N; Liew SH; Morgan FH; Strasser A; Scott CL; Findlay JK; Hickey M; Hutt KJ
Cell Death Dis; 2018 May; 9(6):618. PubMed ID: 29795269
[TBL] [Abstract][Full Text] [Related]
5. Ovarian damage from chemotherapy and current approaches to its protection.
Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes.
Nguyen QN; Zerafa N; Liew SH; Findlay JK; Hickey M; Hutt KJ
Mol Hum Reprod; 2019 Aug; 25(8):433-444. PubMed ID: 30953068
[TBL] [Abstract][Full Text] [Related]
7. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
Bildik G; Akin N; Senbabaoglu F; Sahin GN; Karahuseyinoglu S; Ince U; Taskiran C; Selek U; Yakin K; Guzel Y; Ayhan C; Alper E; Cetiner M; Balaban B; Mandel NM; Esen T; Iwase A; Urman B; Oktem O
Hum Reprod; 2015 Dec; 30(12):2912-25. PubMed ID: 26466909
[TBL] [Abstract][Full Text] [Related]
8. Overactivation or Apoptosis: Which Mechanisms Affect Chemotherapy-Induced Ovarian Reserve Depletion?
Kashi O; Meirow D
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003481
[TBL] [Abstract][Full Text] [Related]
9. Janus kinase JAK1 maintains the ovarian reserve of primordial follicles in the mouse ovary.
Sutherland JM; Frost ER; Ford EA; Peters AE; Reed NL; Seldon AN; Mihalas BP; Russel DL; Dunning KR; McLaughlin EA
Mol Hum Reprod; 2018 Nov; 24(11):533-542. PubMed ID: 30247637
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide.
Luan Y; Edmonds ME; Woodruff TK; Kim SY
J Endocrinol; 2019 Feb; 240(2):243-256. PubMed ID: 30530902
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin obliterates mouse ovarian reserve through both primordial follicle atresia and overactivation.
Wang Y; Liu M; Johnson SB; Yuan G; Arriba AK; Zubizarreta ME; Chatterjee S; Nagarkatti M; Nagarkatti P; Xiao S
Toxicol Appl Pharmacol; 2019 Oct; 381():114714. PubMed ID: 31437492
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced damage to ovary: mechanisms and clinical impact.
Bedoschi G; Navarro PA; Oktay K
Future Oncol; 2016 Oct; 12(20):2333-44. PubMed ID: 27402553
[TBL] [Abstract][Full Text] [Related]
13. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
[TBL] [Abstract][Full Text] [Related]
14. Ovarian Aging in Women With BRCA Germline Mutations.
Lin W; Titus S; Moy F; Ginsburg ES; Oktay K
J Clin Endocrinol Metab; 2017 Oct; 102(10):3839-3847. PubMed ID: 28938488
[TBL] [Abstract][Full Text] [Related]
15. A putative role for anti-Müllerian hormone (AMH) in optimising ovarian reserve expenditure.
Pankhurst MW
J Endocrinol; 2017 Apr; 233(1):R1-R13. PubMed ID: 28130407
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of activator proteins that control follicle reserve after ovarian tissue cryopreservation/transplantation and primordial follicle loss prevention by rapamycin.
Celik S; Ozkavukcu S; Celik-Ozenci C
J Assist Reprod Genet; 2020 Sep; 37(9):2119-2136. PubMed ID: 32651677
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological administration of recombinant human AMH rescues ovarian reserve and preserves fertility in a mouse model of chemotherapy, without interfering with anti-tumoural effects.
Roness H; Spector I; Leichtmann-Bardoogo Y; Savino AM; Dereh-Haim S; Meirow D
J Assist Reprod Genet; 2019 Sep; 36(9):1793-1803. PubMed ID: 31250176
[TBL] [Abstract][Full Text] [Related]
18. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging.
Turan V; Oktay K
Hum Reprod Update; 2020 Jan; 26(1):43-57. PubMed ID: 31822904
[TBL] [Abstract][Full Text] [Related]
19. Ovaries of patients recently treated with alkylating agent chemotherapy indicate the presence of acute follicle activation, elucidating its role among other proposed mechanisms of follicle loss.
Shai D; Aviel-Ronen S; Spector I; Raanani H; Shapira M; Gat I; Roness H; Meirow D
Fertil Steril; 2021 May; 115(5):1239-1249. PubMed ID: 33485607
[TBL] [Abstract][Full Text] [Related]
20. Quercetin prevents primordial follicle loss via suppression of PI3K/Akt/Foxo3a pathway activation in cyclophosphamide-treated mice.
Li J; Long H; Cong Y; Gao H; Lyu Q; Yu S; Kuang Y
Reprod Biol Endocrinol; 2021 Apr; 19(1):63. PubMed ID: 33892727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
